Lin, Tsung-Jung <br/><br/>
Hepatic iron influences responses to combination therapy with peginterferon alfa and ribavirin in chronic hepatitis C.  [electronic resource] 

 -  Hepato-gastroenterology   
 - 1412-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0172-6390 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antiviral Agents--administration & dosage<br/>Drug Therapy, Combination<br/>Female<br/>Ferritins--blood<br/>Hepatitis C, Chronic--blood<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Iron--blood<br/>Male<br/>Middle Aged<br/>Polyethylene Glycols--administration & dosage<br/>Predictive Value of Tests<br/>Recombinant Proteins<br/>Ribavirin--administration & dosage<br/>Transferrin--metabolism<br/>Treatment Outcome<br/>Viral Load